Clinical Trials Browser

Hereditary Breast and Ovarian Cancer Syndrome × Zoledronic Acid × Clear all

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Phase 2 Completed

160 enrolled 10 charts

BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome